Meeting
2014 Gastrointestinal Cancers Symposium
Clinical response to neoadjuvant therapy to predict success of adjuvant chemotherapy for esophageal adenocarcinoma.
Authors
Vernissia Tam
Johns Hopkins Hospital, Baltimore, MD
Vernissia Tam , Craig M. Hooker , Daniela Molena , Alicia Hulbert , Beverly Lee , Lawrence Kleinberg , Stephen C. Yang , Arlene A. Forastiere , Malcolm Brock
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 137)
DOI
10.1200/jco.2014.32.3_suppl.137
Abstract #
137
Poster Bd #
D43
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Predictors of survival after trimodality therapy for esophageal adenocarcinoma: Analysis from the National Cancer Database.
First Author: Oliver Eng
Poster
2021 ASCO Annual Meeting
Survival and organ preservation according to clinical response after total neoadjuvant therapy in locally advanced rectal cancer patients: A secondary analysis from the organ preservation in rectal adenocarcinoma (OPRA) trial.
First Author: Hannah Thompson
Poster
2021 Gastrointestinal Cancers Symposium
Selecting the optimal neoadjuvant treatment approach based on the risk of an involved surgical margin in locally advanced adenocarcinoma of the esophagus and esophagogastric junction.
First Author: Tim Spencer
Poster
2020 ASCO Virtual Scientific Program
A novel gene signature for predicting response to chemoradiotherapy in locally advanced esophageal adenocarcinoma.
First Author: Divya Sahu